Skip to main content
Premium Trial:

Request an Annual Quote

Rob Seitz

Insight Genetics has named Rob Seitz as chief technology officer. As CTO, Seitz will oversee the development and commercialization of Insight's genetic assays for the identification of triple-negative breast cancer using technology licensed out of the Vanderbilt Ingram Cancer Center. Prior to joining Insight, Seitz was senior vice president for technology assessment at Clarient (part of GE Healthcare). He also was co-founder and CEO of Applied Genomics prior to its acquisition by Clarient.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.